Novartis Teams With Pear Therapeutics In Neurological Digital Health Pact
Mar 01 2018
•
By
Sten Stovall
Duo Will Develop Clinically-Validated Software Used for Schizophrenia and MS • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Drug Pricing
More from Scrip
